Keywords: starlix, cleared, eu, novartis, been, awarded, marketing

Starlix cleared in EU

Article | 05 April 2001

Print This

Novartis has been awarded marketing approval in the European Union forStarlix (nateglinide), its drug for the treatment of type 2 diabetes. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in